VENTURINI, PIER LUIGI
 Distribuzione geografica
Continente #
EU - Europa 27.548
AS - Asia 43
SA - Sud America 23
NA - Nord America 1
Totale 27.615
Nazione #
IT - Italia 27.547
SG - Singapore 25
BR - Brasile 20
VN - Vietnam 8
CN - Cina 4
AZ - Azerbaigian 2
ID - Indonesia 2
AR - Argentina 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IQ - Iraq 1
US - Stati Uniti d'America 1
UY - Uruguay 1
Totale 27.615
Città #
Genova 18.753
Genoa 4.999
Rapallo 2.218
Vado Ligure 1.543
Bordighera 34
Ho Chi Minh City 3
Baku 2
Haiphong 2
Rio de Janeiro 2
Ashburn 1
Beijing 1
Bekasi 1
Betim 1
Brasília 1
Bình Dương 1
Caxias do Sul 1
Cuiabá 1
Curitiba 1
Cáceres 1
Erbil 1
Guangzhou 1
Guayaquil 1
Hanoi 1
Hải Dương 1
Inhuma 1
Jakarta 1
Manaus 1
Maringá 1
Montes Claros 1
Montevideo 1
Paty do Alferes 1
Praia Grande 1
Rafael Castillo 1
Recife 1
Sertanópolis 1
Singapore 1
São Bernardo do Campo 1
São Paulo 1
São Roque 1
Taboão da Serra 1
Xiamen 1
Český Těšín 1
Totale 27.589
Nome #
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 224
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 209
Acute presentation of fetal hypertrophic cardiomyopathy in a type 1 diabetic pregnancy. 196
Timing of mid-trimester sacral ossification: reply 185
Drug safety evaluation of desogestrel 184
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies 180
Dedifferrentiated endometrioid adenocarcinoma: report of an highly aggressive lethal case and review of literature. 178
Accuracy of intra-operative frozen section in the diagnosis of borderline ovarian tumors and clinical impact of underdiagnosis 177
Epithelial abnormalities in cystic ovarian endometriosis 166
Fetal spine ossification: The gender and individual differences illustrated by ultrasonography. 165
Endometriotic ovarian cysts do not negatively affect the rate of spontaneous ovulation 164
Abstract book of the 30th ESHRE Annual Meeting, Munich, Germany, 29 June - 2 July 2014 163
Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives 161
Outpatient periurethral injections of polyacrylamide hydrogel for the treatment of female stress urinary incontinence: effectiveness and safety. 161
Triptorelin for the treatment of endometriosis. 160
The preoperative diagnosis of borderline ovarian tumors: a review of current literature 159
Emostasi attraverso elettrocoagulazione con corrente bipolare oppure sutura laparoscopica dopo escissione chirurgica di endometriomi ovarici bilaterali: studio prospettico randomizzato 158
Effect of terguride on prolactin levels in normal, puerperal and hyperprolactinaemic women. 156
Aberrant right subclavian artery in fetuses with Down syndrome: A systematic review and meta-analysis 155
Bevacizumab for the treatment of cervical cancer 154
Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrialhyperplasia. 153
Periurethral injection of polyacrylamide hydrogel for the treatment of stress urinary incontinence: the impact on female sexual function. 153
Bowel endometriosis: Recent insights and unsolved problems 153
OC13.01: Intraoperative ultrasonography during laparoscopic myomectomy 153
Aromatase and endometriosis: estrogens play a role 152
Aromatase inhibitors in the treatment of bladder endometriosis 151
Changes in Sexual Function after Medical or Surgical Termination of Pregnancy 150
Absence of nasal bone and detection of trisomy 21 150
Vaginal sacrospinous colpopexy using the Capio suture-capturing device versus traditional technique: feasibility and outcome 150
Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: Comparative double-blind study 149
Correlation between first trimester fetal bone length and maternal serum pregnancy-associated plasma protein-A (PAPP-A) 149
Efficacy and acceptability of long-term norethindrone acetate for the treatment of rectovaginal endometriosis 149
Triptorelin improves intestinal symptoms among patients with colorectal endometriosis. 148
Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura 148
Proteomics technologies in endometriosis 147
Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results. 147
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 146
Multidetector computerized tomography enema versus magnetic resonance enema in the diagnosis of rectosigmoid endometriosis 146
3-Month Versus 6-Month Treatment With Ulipristal Acetate Prior to Laparoscopic Hysterectomy of Large Myomatous Uteri 146
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review 146
Defective placental adhesion in voluntary termination of second-trimester pregnancy and risk of recurrence in subsequent pregnancies. 145
Bevacizumab in endometrial cancer treatment 145
Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device 145
Apparently isolated borderline ventriculomegaly and lissencephaly. 145
Desogestrel only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study 144
Assessment of Myometrial and Cervical Invasion in Endometrial Cancer by Magnetic Resonance Imaging and 2D, 3D and HDlive Ultrasonography 144
Low total normal motile count values are associated with increased sperm disomy and diploidy rates in infertile patients 143
Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis. 143
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies 143
Imidafenacin for the treatment of overactive bladder 143
Effect of fetal gender on first-trimester ductus venosus blood flow. 143
Frequency of hyper-, hypohaploidy and diploidy in ejaculate, epididymal and testicular germ cells of infertile patients. 143
Gestational choriocarcinoma arising in a cornual pregnancy. 142
Stromal cells from human decidua exert a strong inhibitory effect on NK cell function and dendritic cell differentiation 142
A newly described thoracic vascular malformation in fetuses with Down syndrome. 141
A defective expression of ICAM-1 (CD54) on secretory endometrial cells is associated with endometriosis. 141
Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosis 139
Dienogest in the treatment of endometriosis. 139
Comparing treatments for endometriosis-related pain symptoms in patients with migraine without aura 138
Acute Premature Constriction of the Ductus Arteriosus after Maternal Self-Medication with Nimesulide 137
Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study 137
Aromatase Inhibitors in the Treatment of Endometriosis 136
Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot. 136
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females 135
Current pharmacotherapy for endometriosis. 134
Vaginal danazol in women with rectovaginal endometriosis and pain symptoms persisting after the insertion of the levonorgestrel-releasing intrauterine device. 134
Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. 134
Reproducibility of ductus venosus Doppler flow measurements at 11-14 weeks of gestation 133
The use of sulprostone to induce abortion in the second trimester 133
Trisomy 18 in a fetus with normal NT and abnormal maternal serum biochemistry 132
Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study. 130
Spontaneous fertility after expectant or surgical management of rectovaginal endometriosis in women with or without ovarian endometrioma: a retrospective analysis 130
Real-Time Transvaginal Elastography of Recto-Sigmoid Endometriotic Nodules: Correlation With Symptoms and Histology 130
Reference values for ductus venosus Doppler flow measurements at 10-14 weeks of gestation 129
Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy 129
Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study 129
Reference values for fetal limb biometry at 10-14 weeks of gestation 128
Proteomics technologies in endometriosis. 128
Study of aneuploidy in normal and abnormal germ cells from semen of fertile and infertile men 128
Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. 128
Diagnosis of bowel endometriosis: A review 127
Hemostasis by Bipolar Coagulation Versus Suture After Surgical Stripping of Bilateral Ovarian Endometriomas: A Randomized Controlled Trial 127
Operative time required to perform sacrospinous ligament suspension. 127
Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura 126
A prospective, randomized, controlled clinical study of a new subcutaneous, purified, urinary FSH preparation for controlled ovarian hyperstimulation in in vitro fertilization 126
Intraoperative transrectal ultrasonography for hysteroscopic metroplasty: Feasibility and safety 126
Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study 125
Identification of diverse innate lymphoid cells in human decidua. 125
Ossification timing of sacral vertebrae by ultrasound in the mid-second trimester of pregnancy 124
Accuracy of intraoperative frozen section in the diagnosis of borderline ovarian tumors 124
Dienogest in the treatment of rectovaginal endometriosis: effect on deep dyspareunia and sexual function 124
Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures 123
Luteinizing hormone determinations obtained with either a monoclonal and a polyclonal antibody radioimmunoassay and their correlations with clinical findings 123
Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation 123
Changes in sexual function after medical or surgical termination of pregnancy 123
Ulipristal Acetate Before High Complexity Hysteroscopic Myomectomy: A Retrospective Comparative Study 123
Clinical implications of an anatomical variant of the ductus venosus 123
Effect of lisuride on inhibition of lactation and serum prolactin 122
Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study 122
Prenatal diagnosis of a nasal glioma in the mid trimester 121
Totale 14.403
Categoria #
all - tutte 85.928
article - articoli 76.801
book - libri 0
conference - conferenze 8.330
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 797
Totale 171.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.248 0 0 0 134 86 177 131 142 163 174 125 116
2021/20222.996 60 157 275 325 195 217 200 694 117 264 100 392
2022/20232.683 277 188 45 235 431 495 13 214 489 17 224 55
2023/20241.074 66 166 24 134 81 185 62 76 53 28 42 157
2024/20253.507 98 326 119 272 486 344 314 423 137 169 346 473
2025/20261.597 714 135 300 448 0 0 0 0 0 0 0 0
Totale 27.825